א / / EB128/33 Add.1
א
.
/
. .
/
(
)
: .
*
)
.
/
.(
. .
*
EB128/33 Add.1
/
: / ( ( ) : ) )
(
( (
: )
)
/
/
(
:
)
(
(
)
:
)
/
/
) (
/ (
( :
)
(
:
) )
/
(
:
)
/
(
:
)
.
.
2
ANNEX MEMBERSHIP OF EXPERT ADVISORY PANELS BY PANEL AND REGION Africa N 0 1 0 10 0 1 1 1 0 0 2 7 12 1 3 5 6 0 2 0 2 13 2 9 7 1 1 26 11 8 0 0 0 0 1 4 0 0 2 3 0 0 0 1 9 3 5 5 15 3 10 2 6 4 2 4 1 5 3 0 2 2 6 1 5 0 5 2 0 0 0 2 3 0 2 3 5 2 1 0 4 2 1 2 1 2 0 0 1 1 5 2 1 0 2 1 0 0 0 0 10 0 5 7 12 7 10 4 6 5 1 10 0 3 5 0 0 2 5 4 1 1 3 1 0 2 0 1 1 2 1 2 9 1 0 5 3 4 1 2 1 0 1 0 0 0 4 0 0 2 2 1 0 1 1 0 3 3 0 3 7 6 9 6 1 5 3 1 0 1 2 8 3 0 1 1 2 6 0 1 2 2 0 0 0 1 2 0 1 0 4 0 0 0 2 2 6 4 5 3 2 0 2 1 2 1 0 0 0 0 1 6 1 2 1 0 0 1 3 0 0 1 1 6 9 11 3 6 4 0 0 0 3 0 0 0 0 2 1 6 0 3 1 0 1 1 3 0 0 0 0 0 1 5 0 4 1 0 0 0 4 0 0 0 3 11 18 42 9 19 10 27 5 16 26 54 34 28 15 29 24 6 20 4 14 65 W N W N The Americas N W Europe South-East Asia N W Eastern Mediterranean N W Western Pacific N W Total W 0 4 3 19 1 0 1 12 0 4 6 23 17 7 4 16 10 0 3 1 5 26 % 0 36 17 45 11 0 10 44 0 25 23 43 50 25 27 55 42 0 15 25 36 40
WHO expert advisory panels
Acute bacterial diseases Ageing and health Biological standardization Blood transfusion medicine Cancer Cardiovascular diseases Chronic degenerative diseases (diabetes) Clinical practice guidelines and clinical research methods and ethics Clinical surgical procedures Drug dependence (dependence liability evaluation) Drug dependence and alcohol problems Drug evaluation Drug policies and management Food safety Health laboratory services Health promotion Health science and technology policy Human cell, tissue and organ transplantation Human genetics Immunology Injury and violence prevention and control International pharmacopoeia and pharmaceutical preparations
EB128/33 Add.1
3
4 Africa N W N W N W % The Americas N W Europe Total South-East Asia N W Eastern Mediterranean N W Western Pacific N W 2 0 1 1 0 0 0 2 5 2 0 1 0 1 0 0 0 0 5 4 2 0 1 0 0 94 22% 21 175 59 34% 80 33 41% 0 0 0 0 0 0 0 5 4 5 4 2 0 0 3 1 0 2 0 0 0 3 1 2 3 0 0 1 2 0 0 1 0 0 0 5 4 3 12 1 1 1 247 2 0 1 2 0 0 0 51 21% 5 2 1 2 0 0 0 89 1 0 1 0 0 0 0 27 30% 4 9 3 6 0 0 0 110 0 1 1 2 0 0 0 30 27% 27 24 16 27 4 1 2 795 8 2 3 7 0 0 0 221 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 2 2 0 3 0 1 5 1 5 6 5 5 5 3 1 1 2 1 1 0 0 0 0 1 0 0 0 3 3 0 2 1 0 0 1 0 4 2 0 3 1 1 2 3 6 1 5 0 0 0 1 1 0 0 0 0 0 1 1 1 1 1 3 1 1 0 0 0 1 0 0 0 2 9 4 7 3 0 3 9 2 10 11 5 2 3 1 1 2 0 0 0 2 0 0 0 1 1 0 2 1 0 0 0 0 0 0 0 1 1 0 2 0 2 5 2 1 1 3 2 0 2 1 2 1 0 0 0 0 0 0 2 2 0 0 0 0 1 0 0 0 0 0 0 2 0 2 3 0 0 3 2 2 3 0 3 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 14 7 19 4 4 18 19 21 23 24 16 7 10 4 5 5 2 2 0 2 2 1 4 4 2 4 6 5 1 2 2 1 0 1 0 15 0 29 11 25 10 22 11 19 26 21 6 29 20 25 0 20 0 30 8 19 26 0 0 0 28 Total
EB128/33 Add.1
WHO expert advisory panels
=
=
=
Leprosy Malaria Medicine safety Mental health Neurosciences Nursing Nutrition Oral health Parasitic diseases (filarial infections) Parasitic diseases (general parasitology) Parasitic diseases (leishmaniasis) Parasitic diseases (schistosomiasis) Parasitic diseases (trypanosomiases) Prevention of blindness Prevention of deafness and hearing impairment Rabies Radiation Rehabilitation Sexually transmitted infections including those due to human immunodeficiency virus Traditional medicine Tuberculosis Vector biology and control Virus diseases Virus diseases (antivirals and interferon) Zoonoses
Annex
Number of panel members as at December 2010 where N equals total number of panel members, W the number of women members, and % the percentage of women panel members by panel and region. The figures reflect the total number of experts. Members with more than one nationality are listed in all relevant panels, however they are counted only once in this total.